Pharma Journalist -

JSR Life Sciences (JLS) announced that JSR Corporation has agreed to acquire Selexis SA, a pioneering life sciences company and global leader in mammalian (suspension-adapted CHO-K1)…
Read More...

Axcella announced that Tony Tramontin, Ph.D., has joined the company as Chief Scientific Officer and Senior Vice President of Research & Development. Dr. Tramontin comes to Axcella…
Read More...

Arena Pharmaceuticals announced the appointment of Jennifer Jarrett to the Company's Board of Directors.  Ms. Jarrett has over 20 years of experience as a senior executive and finance…
Read More...

A certain group of genetic faults could be used to help predict if immunotherapy will work in cancer patients, according to a new US study. The research from John Hopkins…
Read More...

Pfizer Inc. and Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for tanezumab for the treatment of chronic pain in…
Read More...

Numab Therapeutics AG announced a collaboration and option agreement with Kaken Pharmaceutical Co., Ltd. for the identification of a multispecific antibody candidate for development in…
Read More...

Astellas Pharma Inc. and Pfizer Inc. announced the amendment of the protocol for the registrational PROSPER trial, a multi-national, randomized, double-blind, placebo-controlled study…
Read More...

Sanofi and Regeneron Pharmaceuticals, Inc. announced positive results from two Phase 3b/4 ODYSSEY-DM trials in patients with diabetes. In the studies, Praluent® (alirocumab), when…
Read More...

Eurofins Scientific announces the acquisition of Alphora Research Inc., a full service contract research, development and manufacturing organization (CRDMO) for complex and niche small…
Read More...

Numerate, Inc., a computational drug design company applying artificial intelligence (AI) at cloud scale to transform small molecule drug discovery, announced the formation of a…
Read More...